Compile Data Set for Download or QSAR
Report error Found 505 Enz. Inhib. hit(s) with all data for entry = 9951
TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502377(N-[4-(7- methoxy-1- methyl- [1,2,4]tri- azolo[4,3-...)
Affinity DataIC50: 0.400nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502344(2-methoxy-N- {4-[1-methyl- 7-(1-methyl- 1H-benzo- ...)
Affinity DataIC50: 0.600nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502348(3-methyl-N- {4-[1-methyl- 7-(1-propyl- 1H- benzoim...)
Affinity DataIC50: 0.900nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502328(US11028090, Example 222)
Affinity DataIC50: 1nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502334(N-{4-[7-(5,6- dimethoxy- 1H-benzo- imidazole-2- yl...)
Affinity DataIC50: 1nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502479((S)-(1-{4-[7- (2-methoxy- ethoxy)-1- methyl- [1,2,...)
Affinity DataIC50: 1nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502480((S)-(1-{4-[7- (2-methoxy- ethoxy)-1- methyl- [1,2,...)
Affinity DataIC50: 1nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502481((S)-(1-{4-[7- (2-methoxy- ethoxy)-1- methyl- [1,2,...)
Affinity DataIC50: 1nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502494(2,3- dichloro-N- {4-[7-(2- methoxy- ethoxy)-1- met...)
Affinity DataIC50: 1nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502217(N-[4-(7,8- dimethoxy-1- methyl-[1,2,4] triazolo[4,...)
Affinity DataIC50: 2nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502290([4-(7,8- diethoxy-1- methyl- [1,2,4]triazolo [4,3-...)
Affinity DataIC50: 2nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502340(2,2-difluoro- N-{4-[1- methyl-7-(1- methyl-1H- ben...)
Affinity DataIC50: 2nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502343(4-methyl- pentanoic acid-{4-[1- methyl-7- (1-meth...)
Affinity DataIC50: 2nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502455({4-[7-(2- methoxy- ethoxy)-1- methyl- [1,2,4]tri- ...)
Affinity DataIC50: 2nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502471(2-(S)- hydroxy-N- {4-[7-(2- methoxy- ethoxy)-1- me...)
Affinity DataIC50: 2nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502501(N-{4-[7-(2- methoxy- ethoxy)-1- methyl- [1,2,4]tri...)
Affinity DataIC50: 2nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502336({4-[1-methyl- 7-(1-methyl- 1H-benzo- imidazole-2- ...)
Affinity DataIC50: 3nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502466(4-methyl- pentanoic acid{4-[7- (2-methoxy- ethoxy)...)
Affinity DataIC50: 3nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502475(3-cyclopentyl- N-{4-[7-(2- methoxy- ethoxy)-1- met...)
Affinity DataIC50: 3nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502502(1-isopropyl-3- {4-[7-(2- methoxy- ethoxy)-1- methy...)
Affinity DataIC50: 3nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502252(2-(S)-hydroxy-N- [4-(8-methoxy- 1-methyl-[1,2,4] t...)
Affinity DataIC50: 4nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502276([4-(8- methoxy-1,6- dimethyl- [1,2,4]triazolo [4,3...)
Affinity DataIC50: 4nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502288([4-(7,8- diethoxy-1- methyl- [1,2,4]triazolo [4,3-...)
Affinity DataIC50: 4nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502331(N-{4-[7-(1H- benzo- imidazole-2- yl)-1-methyl- [1,...)
Affinity DataIC50: 4nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502392(2-(R)- hydroxy-N- [4-(7- methoxy-1- methyl- [1,2,4...)
Affinity DataIC50: 4nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502412((S)-{1-[4- (7-methoxy- 1-methyl- [1,2,4]tri- azolo...)
Affinity DataIC50: 4nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502449({4-[7-(2- methoxy- ethoxy)-1- methyl- [1,2,4]triaz...)
Affinity DataIC50: 4nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502157(2-(S)- hydroxy-N- [4-(1- methyl- [1,2,4] triazolo ...)
Affinity DataIC50: 5nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502213(4-methyl- pentanoic acid [4-(7,8- dimethoxy-1- met...)
Affinity DataIC50: 5nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502450(US11028090, Example 367 | {4-[7-(2- methoxy- ethox...)
Affinity DataIC50: 5nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502465(N-{4-[7-(2- methoxy- ethoxy)-1- methyl- [1,2,4]tri...)
Affinity DataIC50: 5nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502473(2,2- difluoro-N- {4-[7-(2- methoxy- ethoxy)-1- met...)
Affinity DataIC50: 5nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502527(US11028090, Example 448)
Affinity DataIC50: 5nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502557(2-(S)- hydroxy-N- [4-(7- methoxy-1- methyl-8- trif...)
Affinity DataIC50: 5nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502566(4-(7- imidazole- 1-yl-1- methyl- [1,2,4]triazolo[4...)
Affinity DataIC50: 5nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502637(US11028090, Example 579)
Affinity DataIC50: 5nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502640(US11028090, Example 583)
Affinity DataIC50: 5nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502641(N-{4-[7- (3,5- dimethyl- isoxazol-4- yl)-1- methyl...)
Affinity DataIC50: 5nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502656(US11028090, Example 623 | [4-(7- methoxy-1- ethyl-...)
Affinity DataIC50: 5nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502179(US11028090, Example 39)
Affinity DataIC50: 6nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502261(2-(S)- hydroxy-N- [4-(6- methoxy- 1,7- dimethyl- [...)
Affinity DataIC50: 6nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502341(2-(S)- hydroxy-3- methyl-N-{4- [1-methyl-7- (1-met...)
Affinity DataIC50: 6nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502470(2-(R)- hydroxy-N- {4-[7-(2- methoxy- ethoxy)-1- me...)
Affinity DataIC50: 6nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502196([4-(7,8- dimethoxy- 1-methyl-[1,2,4] triazolo[4,3-...)
Affinity DataIC50: 7nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502335({4-[1-methyl- 7-(1-methyl- 1H-benzo- imidazole-2- ...)
Affinity DataIC50: 7nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502349(N-(4-{7-[1- (2-methoxy- ethyl)-1H- benzoimid- azol...)
Affinity DataIC50: 7nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502360(N-{4-[7-(3- cyano- propylamino)- 1-methyl- [1,2,4]...)
Affinity DataIC50: 7nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502393(2-(S)- hydroxy-N- [4-(7- methoxy-1- methyl- [1,2,4...)
Affinity DataIC50: 7nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502417(2-(S)-(2- (S)-hydroxy- propionylami- no)-N-[4-(7- ...)
Affinity DataIC50: 7nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502445(US11028090, Example 358)
Affinity DataIC50: 7nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 505 total ) | Next | Last >>
Jump to: